Alexandre (Sasha) Akoulitchev, MA(Oxon), PhD(UCL), FRSM

Chief Scientific Officer & Co-Founder, Oxford Biodynamics

Lori Anderson

Product Marketing Manager, XIFIN, Inc.

Ardy Arianpour, MBA

CEO & Co-Founder, Seqster

Kristine Ashcraft, MBA

Kristine Ashcraft, MBA

CEO & Founder, YouScript

Steven D. Averbuch, MD

Precision Medicine and Oncology Rx/Dx Development, S D Averbuch Consulting, LLC

Dawn Barry, MBA

President & Co-Founder, LunaPBC

Gabriel A. Bien-Willner, MD, PhD, FCAP

Medical Director, MolDx, Chief Medical Officer, Palmetto GBA

Coco Brown

Founder, CEO, COO, Board Director and Advisor, The Athena Alliance

Trish Brown

Director; AMR Payor Partner and Field Market Access Lead, Illumina

Alessandra Cesano, MD, PhD

Chief Medical Officer, ESSA

Julie Collens, PhD

CEO Vivid Genomics

Chris Cournoyer, MA, MIT Executive Education Program

Strategic Advisor, Qiagen

Sean Downing, PhD, MBA

Director Customer Engagement, Ultivue

Nicholas Dracopoli, PhD

Chief Scientific Officer, Delfi Diagnostics, Inc.

Teresa Foy, PhD

Corporate Vice President, Head, Immuno-Oncology and Cellular Therapy, Thematic Center for Excellence, Celegene

Jessica Gibson, MBA

CEO & Co-Founder, Ariel Precision Medicine

Sean Glenn, PhD

Vice President of Clinical & Research Development, OmniSeq

Robert Green, MD, MPH

Associate Physician, Brigham and Women’s Hospital, Professor of Medicine, Harvard Medical School, Geneticist, Brigham and Women’s Hospital, Director, Genomes2People Research Program

Karen Gutekunst, PhD

Vice President Regulatory Affairs, Illumina

Anne-Renee Hartman, MD

Vice President of Clinical Development & Medical Affairs, GRAIL

Michael Heltzen, MBA

Chief Executive Officer and Board Member,Cardea Bio

Laura Holmes Haddad

Best Selling Author & Patient Advocate

David Houlding, MSc, CISSP, CIPP

Principal Healthcare Lead, Microsoft

Sally Howard, JD

Principal, Sally Howard Regulatory Resources

Leighton Howells

Vice President Business Development, RareCyte

Mark Kiel, MD, PhD

Founder and Chief Scientific Officer, Genomenon

Tara Kochis-Stach

President, Slone Partners

Gail Marcus, MBA, MSE, PhD

Professor, Massachusetts College of Pharmacy & Health Sciences University

Marielena Mata, PhD

Director and Diagnostic Lead, Pfizer

Brian Meyer, PhD

Chairman, Department of Genetics Research Centre, KFSH&RC

Chockalingam “Palani” Palaniappan, PhD

Chief Technology Officer, Epic Sciences

John Rossi, MS

Director, Translational Medicine, Kite, A Gilead Company

Hakan Sakul, PhD

Vice President and Head of Diagnostics, Worldwide Research, Development & Medical, Pfizer

Jordi Serrats, PhD

Associate Director Neuroscience Drug Discovery Unit, External Neuroscience Innovation, Takeda

Roy Smythe, MD

Chief Executive Officer, SomaLogic

David Spetzler, MS, MBA, PhD

President and Chief Scientific Officer, Caris Life Sciences

Mary Stutts, MHA, Executive Program Graduate, Stanford University School of Business

Chief Diversity, Inclusion & Health Equity Officer at Stanford Healthcare

Tim Triche, MD, PhD

Professor, Pathology & Pediatrics, Keck School of Medicine at USC, Co-Director, Center for Personalized Medicine, Childrens’ Hospital Los Angeles

John Quackenbush, PhD

Henry Pickering Walcott Professor of Computational Biology and Bioinformatics
Chair, Department of Biostatistics, Harvard University T.H. Chan School of Public Health

Bruce Quinn, MD, PhD

Principal, Bruce Quinn Associates LLC

Christina Waters, MBA, PhD

CEO, RARE Science, Precision Medicine Council – World Economic Forum

Roseanne Welcher, PhD, MBA

Chief Scientific Officer, Agilent Technologies